Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Theseus Pharmaceuticals Inc (NQ: THRX ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Feb 13, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 4.060 (3) Ask (Size) 4.070 (1) Prev. Close 4.060 Today's Range N/A - N/A 52wk Range 3.260 - 4.200 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News THESEUS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Theseus Pharmaceuticals, Inc. - THRX December 31, 2023 From Kahn Swick & Foti, LLC Via Business Wire Small-Cap Cancer Focused Theseus Pharmaceuticals Goes Private For Over $3.90/Share In Cash December 22, 2023 Theseus Pharmaceuticals Inc (NASDAQ: THRX) on Friday, has entered into a definitive merger agreement whereby Concentra Biosciences LLC will acquire Theseus for a price per share of between $3.90 and... Via Benzinga Performance More News Read More THRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Theseus Pharmaceuticals, Inc. Is Fair to Shareholders December 22, 2023 From Halper Sadeh LLC Via Business Wire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday November 27, 2023 Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's After-Market Session November 14, 2023 Via Benzinga Dow Jumps Over 500 Points; Home Depot Earnings Top Views November 14, 2023 Via Benzinga Topics Stocks Exposures US Equities Crude Oil Moves Higher; Beauty Health Shares Plunge November 14, 2023 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Nasdaq Surges 2%; US Inflation Rate Slows In October November 14, 2023 Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session November 14, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session November 14, 2023 Via Benzinga Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket November 14, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday November 14, 2023 Via InvestorPlace Deciphera Pharmaceuticals Sees Renewed Competitive Edge After Theseus Pan-KIT Discontinuation: Analyst August 10, 2023 Via Benzinga Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session July 20, 2023 Via Benzinga $2M Bet On Molecular Templates? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying July 20, 2023 Via Benzinga Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month July 18, 2023 Via Benzinga Nasdaq Drops 50 Points; Wells Fargo Earnings Beat Views July 14, 2023 Via Benzinga Setback For Theseus Pharmaceuticals: Analysts Cut Price Targets But Remain Bullish On Stock July 14, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session July 14, 2023 Via Benzinga Crude Oil Down 2%; Citigroup Profit Tops Estimates July 14, 2023 Via Benzinga Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session July 14, 2023 Via Benzinga Dow Jumps 150 Points; JPMorgan Posts Upbeat Earnings July 14, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023 July 14, 2023 Via Benzinga PLUG Stock Alert: Plug Power Pops on Analyst Upgrade July 14, 2023 Via InvestorPlace Dose-Limiting Toxicities: Theseus Pharma Terminates THE-630 Study For Gastrointestinal Cancer July 14, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
